semaglutide vs tirzepatide chart vs retatrutide: the complete three-way comparison Comparative Cardiovascular Pharmacovigilance of Semaglutide

According to US obesity treatment guidelines, clinicians should consider whether to continue therapy if a patient has not lost at least 5% of baseline weight after approximately 3 months on the maintenance dose

Steady use and regular follow-up visits support the best outcomes

Wegovy (semaglutide injection): Another weekly option, Wegovy is designed for individuals dealing with obesity or overweight conditions with associated health concerns

Son ejemplos de casos con el mismo principio activo, pero usos distintos

Dungan KM, Bardtrum L, Christiansen E et al (2023) Greater combined reductions of HbA 1c 1.0% and body weight loss 5.0% or 10.0% with orally administered semaglutide versus comparators

How is semaglutide GLP-1 good for medical weight loss